Atherosclerosis — Clinical Documentation Guide (2026)

🔍 Definition

Atherosclerosis is a chronic, systemic inflammatory disease of the arterial wall characterized by the progressive accumulation of lipid-laden plaques (atheromas) within the intima of medium- and large-caliber arteries. The process begins with endothelial dysfunction, followed by lipoprotein infiltration, macrophage recruitment, foam cell formation, fibrous cap development, and ultimately plaque vulnerability, ulceration, rupture, or calcification. The result is progressive luminal narrowing, reduced arterial compliance, and—when plaques become unstable—acute thrombotic events including myocardial infarction, stroke, and limb ischemia.

Per the FY2026 ICD-10-CM Tabular List, atherosclerosis is classified primarily under category I70 (Atherosclerosis), with subcategories organized by vessel territory (aorta, renal artery, extremity arteries, bypass grafts). Related cerebrovascular and coronary manifestations are coded under I65–I67 and I25, respectively. This guide addresses the systemic (general) spectrum of atherosclerosis; for coronary artery disease see the CAD CDG (I25.x), and for peripheral arterial disease of the lower extremities see the PVD CDG (I70.2xx).

🗂️ Alternative Terminology

The following terms are commonly encountered in clinical documentation and each maps to specific ICD-10-CM codes. Coders must query when the term is ambiguous or when a more specific anatomical code is available.

🩺 Signs & Symptoms

Clinical presentation of atherosclerosis varies by vessel territory. Many patients are asymptomatic until significant luminal stenosis (>70%) or plaque rupture occurs. Common presentations include:

• Cardiovascular: Exertional chest pain/angina (CAD), dyspnea on exertion, palpitations; acute MI when plaque ruptures in coronary territory
• Cerebrovascular: Transient ischemic attack (TIA), amaurosis fugax, focal neurological deficits, stroke (when carotid/vertebral stenosis causes embolism or perfusion failure)
• Peripheral (lower extremity): Intermittent claudication, rest pain, non-healing wounds/ulcers, gangrene; cold, pale, or mottled extremities; diminished or absent pedal pulses; reduced ankle-brachial index (ABI)
• Renal: Renovascular hypertension (refractory to multiple antihypertensives), progressive chronic kidney disease, flash pulmonary edema (Pickering syndrome)
• Aortic: Often asymptomatic; may present with abdominal/back pain if aneurysmal dilation occurs; mesenteric ischemia (post-prandial pain, weight loss) in visceral artery involvement
• Mesenteric: Abdominal angina, weight loss, post-prandial pain

Physical exam findings include carotid bruits, diminished peripheral pulses, prolonged capillary refill, trophic skin changes (hair loss, shiny skin, nail dystrophy), and funduscopic evidence of retinal arterial narrowing. Ankle-brachial index (ABI) <0.9 is diagnostic for PAD per ACC/AHA guidelines.

🧭 Differential Diagnosis

📋 Clinical Indicators for Coders/CDI

The following clinical indicators support the diagnosis and assignment of atherosclerosis codes. Documentation in the medical record should reflect these findings to justify code assignment and support HCC capture.

🦴 Anatomy & Pathophysiology

Atherosclerosis affects large- and medium-sized arteries. The primary affected vessel territories, their ICD-10 classifications, and clinical relevance are:

• Aorta (I70.0): The aorta is the most common site for early plaque deposition, particularly the abdominal aorta near the renal ostia and iliac bifurcation. Aortic atherosclerosis increases the risk of aneurysmal dilation, peripheral embolism, and serves as the proximal source for iliac/femoral disease.
• Renal arteries (I70.1): Ostial and proximal renal artery plaques cause renal artery stenosis, reducing renal perfusion, activating the renin-angiotensin-aldosterone system (RAAS), and producing renovascular hypertension. Progressive stenosis leads to ischemic nephropathy.
• Extremity arteries (I70.2xx–I70.7xx): The infrainguinal territory (superficial femoral, popliteal, tibial arteries) is most commonly involved. Disease severity ranges from asymptomatic stenosis to intermittent claudication, rest pain, tissue loss (ulceration), and gangrene—classified as Fontaine stages I–IV or Rutherford categories 0–6.
• Carotid/cerebral arteries (I65.x, I66.x, I67.2): Extracranial carotid bifurcation plaques are the most common source of embolic stroke. Intracranial atherosclerosis (I66.x) causes ischemic stroke by thrombosis or hemodynamic compromise. Cerebral atherosclerosis (I67.2) represents chronic non-infarct intracranial disease.

Pathophysiologic cascade per Libby et al., NEJM:

1. Endothelial dysfunction — Risk factors (hypertension, dyslipidemia, diabetes, smoking) impair NO production and upregulate adhesion molecules (VCAM-1, ICAM-1).
2. LDL oxidation and subendothelial accumulation — LDL particles penetrate the intima and undergo oxidative modification.
3. Monocyte recruitment and foam cell formation — Monocytes migrate into the intima, differentiate into macrophages, engulf oxidized LDL, and become lipid-laden foam cells forming the fatty streak.
4. Smooth muscle cell migration and fibrous cap formation — Cytokines drive VSMCs from media to intima, producing a fibrous cap that may stabilize or destabilize the plaque.
5. Plaque vulnerability and rupture — Thin-cap fibroatheromas with large lipid cores and inflammatory infiltrates are prone to rupture, triggering acute thrombosis and clinical events (MI, stroke, acute limb ischemia).
6. Calcification — Dystrophic calcification of necrotic cores can increase plaque rigidity; coronary artery calcium (CAC) scoring quantifies burden.

💊 Medication Impact / Treatment

Pharmacological management of atherosclerosis targets primary risk factors and plaque stabilization. The following drug classes are most relevant for coders and CDI specialists:

Interventional/surgical treatments (relevant for procedure coding) include endovascular revascularization (angioplasty, stenting, atherectomy), bypass surgery (aortofemoral, femoropopliteal, tibial), carotid endarterectomy (CEA), renal artery stenting, and aortic grafting. These are addressed in the CPT section below.

Preview ends here. The full guide continues with FY2026 ICD-10-CM code sets, CPT surgical coding, MS-DRG mapping, reimbursement guidance, CDI query templates, and an audit checklist — all available to CCO Members.

← Back to All Clinical Documentation Guides

📘 ICD-10-CM Guidelines (FY2026)

The following official coding guidelines from the FY2026 ICD-10-CM Official Guidelines for Coding and Reporting (CMS) are critical for accurate atherosclerosis coding:

Section I.C.9 — Diseases of the Circulatory System

• Atherosclerosis with bilateral involvement: When atherosclerosis affects both extremities, codes from I70.2xx–I70.7xx are assigned for each affected extremity separately. Do not assign a single “bilateral” code unless one is specifically provided in the Tabular.
• Chronic total occlusion (I70.92): This code is used as an additional code with codes from I70.2–I70.7 when chronic total occlusion of an artery of the extremities is present. It is not a standalone code. Documentation must explicitly state “chronic total occlusion” — stenosis alone does not support this code.
• Atherosclerosis of bypass graft (I70.3xx–I70.7xx): These codes apply to patients with prior bypass surgery who now have atherosclerosis developing within or involving the graft itself. The type of graft (autologous vein, nonautologous biological, nonbiological, other type) drives subcategory selection. Query the operative note or surgical history when documentation is unclear.
• Etiology/Manifestation convention: When atherosclerosis is the underlying condition causing a manifestation (e.g., gangrene, ulceration, rest pain), the atherosclerosis code includes the manifestation within its subcategory structure (e.g., I70.261 = atherosclerosis of native arteries of extremities with gangrene, right leg). Do not assign separate gangrene code (I96) unless the Tabular directs otherwise.
• Diabetic peripheral angiopathy (E11.51–E11.59): When a patient has both diabetes and atherosclerosis of the extremities, ICD-10-CM guideline Section I.C.4.a instructs coders to presume a relationship between the two unless the provider states they are unrelated. Assign E11.51x or E11.52x (with/without gangrene) as the principal or sequenced appropriate code, with the I70.2xx code as additional if both are independently documented and clinically distinct.

Sequencing Considerations

• For inpatient encounters, the condition most responsible for admission determines the principal diagnosis. Atherosclerosis complications (acute limb ischemia, rest pain with tissue loss) often drive admission.
• For outpatient/physician encounters, the condition that prompted the visit is listed first.
• When coding I65.x or I66.x (carotid/cerebral artery occlusion/stenosis), these are used when the condition does NOT result in a current cerebral infarction. If infarction has occurred, code from I63.x instead, and I65.x/I66.x are generally not additionally assigned unless the Tabular specifically instructs.

🔢 ICD-10-CM Code Set (FY2026)

All codes verified against the FY2026 ICD-10-CM Tabular List (CMS). Codes marked † require 7th character extension; see subcategory for valid options.

Category I70 — Atherosclerosis (Primary)

Related Coronary Atherosclerosis (I25.x)

Carotid and Cerebrovascular Atherosclerosis (I65.x, I66.x, I67.2)

Other Related Arterial Codes

Diabetic Peripheral Angiopathy (E11.5x)

Status / Screening / History Codes

🔎 Indexing

The ICD-10-CM Alphabetic Index pathways for atherosclerosis-related conditions are critical for accurate code selection. The following entry points are most commonly used:

• Atherosclerosis / Arteriosclerosis → I70.90 (default); sub-entries: aorta → I70.0; renal artery → I70.1; extremities → I70.20 (with severity/laterality sub-entries); bypass graft → sub-entries by graft type I70.30x–I70.70x; generalized → I70.91; cerebral → I67.2
• Stenosis, carotid (artery) → I65.2x (note: verify specificity; carotid = I65.01–I65.03; basilar = I65.1; vertebral = I65.0x)
• Disease, peripheral vascular (occlusive) → I73.9 [⚠️ No HCC — see CDI note above]
• Occlusion, artery, chronic total → I70.92 (additional code); must use with I70.2–I70.7
• Diabetes / diabetic, angiopathy, peripheral → E11.51 (without gangrene); E11.52 (with gangrene)
• Aneurysm, aorta / artery → I71.x / I72.x — see Aortic Aneurysm CDG

🏥 CPT (2026)

CPT codes verified against the AMA CPT 2026 code set. Global periods per CMS MPFS.

Vascular Imaging — Diagnostic

Endovascular Revascularization — Lower Extremity

Open Bypass Surgery

Coronary revascularization (PCI 92920–92944): See the CAD CDG for complete PCI coding guidance.

🧾 HCPCS (2026)

📚 AHA Coding Clinic (Recent Guidance)

The AHA Coding Clinic for ICD-10-CM/PCS provides authoritative guidance on complex coding scenarios. The following advisories are most relevant for atherosclerosis:

• Coding Clinic 2019, Q4: Confirmed that I70.92 (Chronic total occlusion of artery of the extremities) requires explicit provider documentation of “chronic total occlusion” — angiographic description alone (e.g., “100% occlusion”) is insufficient without clinical correlation and physician attestation.
• Coding Clinic 2018, Q4: Addressed sequencing of diabetic peripheral angiopathy (E11.51/E11.52) vs. I70.2xx. When both conditions are independently documented and clinically addressed, both codes are reported; sequencing depends on the reason for the encounter.
• Coding Clinic 2016, Q3: Clarified that atherosclerosis of bypass grafts (I70.3xx–I70.7xx) applies to disease in or of the graft itself, not simply disease in the native artery proximal to a graft. Query when documentation is unclear about location of disease.
• Coding Clinic 2016, Q1: Addressed reporting of I70.0 (atherosclerosis of aorta) when incidentally documented on imaging (e.g., CT reporting aortic calcification). Confirmed this is reportable as an additional code when documented by the treating provider as a current condition.
• Coding Clinic 2014, Q2: Confirmed that I65.x codes (occlusion/stenosis of precerebral arteries) are used ONLY when there is no cerebral infarction. When infarction occurs, code from I63.x — I65.x is not additionally assigned unless Tabular specifically instructs otherwise.

💰 HCC / Risk Adjustment (v28)

The following HCC mappings reflect the CMS-HCC Model v28, effective for payment year 2026 (using 2024 diagnoses). RAF weights are approximate and are derived from the CMS risk adjustment software; actual payment impact depends on patient demographics and interaction terms.

✍️ CDI Query Templates

The following query templates are designed to be clinically compliant, non-leading, and multiple-choice per ACDIS CDI Query Standards and AHIMA query practice standards.

🧑‍⚕️ Treatments (Clinical)

Atherosclerosis management follows a tiered approach based on disease location, severity, and patient risk profile, as outlined in the 2024 ACC/AHA Guideline for Peripheral Artery Disease and the 2023 ACC/AHA Guideline on Chronic Coronary Disease:

Medical / Lifestyle Management

• Intensive lipid-lowering: High-intensity statin therapy (atorvastatin 40–80 mg, rosuvastatin 20–40 mg) targeting LDL-C <70 mg/dL for ASCVD, <55 mg/dL for very high risk. Add ezetimibe or PCSK9 inhibitor if LDL-C goal not achieved.
• Antiplatelet therapy: Aspirin 75–100 mg daily for established ASCVD (secondary prevention). Clopidogrel 75 mg as alternative or in combination post-revascularization. Z79.82 documents aspirin use.
• Blood pressure control: Target <130/80 mmHg per ACC/AHA 2017 HTN guidelines; ACE inhibitors/ARBs preferred in patients with CKD or LV dysfunction.
• Blood glucose management (diabetics): GLP-1 agonists (semaglutide, liraglutide) and SGLT-2 inhibitors (empagliflozin, canagliflozin) have demonstrated ASCVD mortality benefit beyond glycemic control.
• Smoking cessation: Single most impactful modifiable risk factor reduction for PAD progression; nicotine replacement, varenicline, bupropion.
• Supervised exercise therapy: 36 sessions of supervised exercise recommended for claudication (Class I evidence); improves walking distance by up to 50–200%; covered under Medicare CMS NCD 20.35.

Endovascular Interventions

• Percutaneous transluminal angioplasty (PTA): Balloon dilation of stenotic segments; most effective in aortoiliac territory (TASC A/B lesions)
• Stenting: Bare metal stents (BMS) or drug-eluting stents (DES) to maintain vessel patency after PTA; iliac stenting shows superior long-term patency over PTA alone
• Drug-coated balloons (DCB): Paclitaxel-coated balloons for femoropopliteal disease reduce restenosis rates
• Atherectomy: Directional, rotational, orbital, or laser atherectomy for calcified or in-stent restenosis lesions
• Carotid artery stenting (CAS): For high surgical risk patients with symptomatic carotid stenosis >50% or asymptomatic stenosis >80%; embolic protection device required

Surgical Interventions

• Carotid endarterectomy (CEA): Standard for symptomatic carotid stenosis >50% or asymptomatic >60–70%; CPT 35301
• Aortobifemoral bypass: Gold standard for aortoiliac occlusive disease (Leriche syndrome); CPT 35646
• Infrainguinal bypass: Femoropopliteal or fem-tibial bypass for critical limb ischemia when endovascular options exhausted; autologous vein preferred conduit
• Renal artery revascularization: Renal artery stenting for atherosclerotic RAS causing resistant hypertension or ischemic nephropathy (CORAL trial results temper enthusiasm for intervention in stable patients)
• Amputation: When limb salvage is not feasible (unsalvageable gangrene, sepsis); major amputation (above/below knee) is the last resort after revascularization failure

🎓 Patient Education / Summary

Atherosclerosis is a lifelong, progressive condition that affects arteries throughout the body. The following key points support patient engagement and shared decision-making:

What is Atherosclerosis?

Atherosclerosis occurs when the walls of arteries — the blood vessels that carry oxygen-rich blood from your heart to the rest of your body — become thickened and narrowed by a buildup of fatty plaques. Over time, these plaques can harden (calcify), reduce blood flow, or rupture and trigger dangerous blood clots. The condition can affect arteries in the heart (causing heart attacks), brain (causing strokes), legs and feet (causing painful cramping, wounds, or gangrene), and kidneys (causing high blood pressure and kidney damage).

Key Risk Factors

• High LDL (“bad”) cholesterol and low HDL (“good”) cholesterol
• High blood pressure (hypertension)
• Diabetes mellitus (especially poorly controlled)
• Cigarette smoking — the most powerful modifiable risk factor
• Obesity (especially abdominal/central obesity)
• Sedentary lifestyle and poor diet (high in saturated fat, trans fats, processed foods)
• Family history of heart attack, stroke, or peripheral artery disease
• Age (risk increases significantly after age 45 in men, 55 in women)

Warning Signs to Report

• Leg pain, cramping, or fatigue when walking that stops with rest (claudication)
• Chest pain, pressure, or tightness — especially with exertion
• Sudden weakness, numbness, speech problems, or vision changes (possible TIA or stroke — call 911 immediately)
• Non-healing sores or wounds on feet or legs
• Coldness, discoloration, or numbness in one or both feet

What You Can Do

• Take your medications as prescribed — statins, blood pressure medications, and aspirin work best when taken consistently every day
• Stop smoking — ask your doctor about cessation programs, nicotine replacement, or medications like varenicline
• Exercise regularly — aim for at least 30 minutes of moderate activity most days; supervised walking programs are especially effective for leg artery disease
• Eat a heart-healthy diet — rich in vegetables, fruits, whole grains, lean protein, and healthy fats; limit salt, sugar, and processed foods
• Monitor and control blood sugar if you have diabetes — work with your care team to keep A1C below target
• Attend all follow-up appointments — atherosclerosis requires ongoing monitoring; imaging studies (duplex ultrasound, ABI) track disease progression

Living with Atherosclerosis

Atherosclerosis cannot be cured, but it can be effectively managed and its progression slowed — or in some cases partially reversed — with aggressive risk factor control. Patients who maintain LDL-C below 70 mg/dL, control blood pressure and blood sugar, stop smoking, exercise regularly, and take prescribed medications can significantly reduce their risk of heart attack, stroke, and limb loss. Research-based tools like the ACC/AHA ASCVD Risk Calculator help clinicians and patients understand 10-year cardiovascular event risk and prioritize interventions.

For coders and CDI specialists: Ensuring complete and specific diagnosis documentation — including vessel site, laterality, severity, and systemic burden — directly supports accurate risk adjustment, fair reimbursement, and quality metric reporting for patients living with this high-prevalence, high-impact condition.

About this Guide

This Clinical Documentation Guide is published by CCO Academy and is intended for credentialed coding, CDI, and clinical documentation professionals. Content is updated for FY2026 ICD-10-CM (effective October 1, 2025). All code assignments should be verified against the official ICD-10-CM Tabular List, AHA Coding Clinic, and applicable payer-specific policies. This guide does not constitute legal, medical, or compliance advice.

Last reviewed: April 2026 · Next scheduled review: October 2026 (FY2027 update)